|
NR 4-6/2007
|
|
|
|
|
|
|
|
|
Zastosowanie
iniekcji octanu triamcinolonu w leczeniu torbielowatego obrzęku
plamki w przebiegu makulopatii cukrzycowej
Intravitreal triamcinolone
acetonide injections in treatment of cystoid macular edema due
to diabetic maculopathy
Anna Lubczyńska, Jarosław Kocięcki
Z Katedry i Kliniki Okulistyki Akademii Medycznej w Poznaniu
Kierownik: dr hab. n. med. Jarosław Kocięcki |
|
|
| Summary: |
Purpose: To appoint the
most adequate follow-up parameter of intravitreal TA
injections in CME treatment due to diabetic maculopathy
and to find the most reliable treatment scheme Material
and method: 4 mg (in 0,1 ml) of crystalline TA were
injected into the vitreous of 17 eyes.
Results: There was a statistically significant
improvement of BCVA for distance and near vision. There
was statistically significant difference in retinal
thickness outcomes measured at baseline and at the end
of the follow-up by both OCT and RTA No correlation of
BCVA changes and retinal thickness changes measured in
OCT and RTA was found. Conclusions: Intravitreal TA
administration seems to be an effective method of
treatment in diabetic CME. OCT is the most adequate
method of follow-up of intravitreal TA injections in
treatment of CME due to diabetic maculopathy. RTA and FA
changes analysis are alternative monitoring methods.
Dosage of 4mg TA in 0.1 ml seems to be sufficient. In
cases of CME recurrence subsequent intravitreal
injection in the first 6 month after initial injection
seems to unnecessary. |
| Słowa kluczowe: |
makulopatia cukrzycowa,
torbielowaty obrzęk plamki, octan triamcinolonu. |
| Key words: |
diabetic maculopathy,
cystoid macula edema, triamcinolone acetonide. |
|
|
|
|
|
|
